Information Collection

Testing FDA's Drug Safety Communications with Consumers to Improve Consumer Knowledge about How FDA Communicates Risks and Benefits of Prescription Medicines

IC 212699 under ICR 201401-0910-003 · OMB 0910-0677.

Information Collection (IC) Details

View Information Collection (IC)

layout table

Information Collection Instruments:
table that charts list of instruments
Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Screener DSC Focus Group Screener Final.docx No   Printable Only
Other-Moderator's guide DSC Moderator's Guide_Final OMB_.doc No   Printable Only

Federal Enterprise Architecture Business Reference Module


table that charts list of burden
  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 216 0 216 0 0 0
Annual IC Time Burden (Hours) 432 0 432 0 0 0
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Documents for IC
table that charts IC Documents
Title Document Date Uploaded
DSC Example 1 testosterone DSC Example 1_testosterone_Final.docx 08/20/2014
DSC Example 2 Sodium Phosphate DSC Example 2_Sodium Phosphate_Final.docx 08/20/2014
DSC Example 3 Fentanyl DSC Example 3_fentanyl_Final.docx 08/20/2014
DSC Testosterone pdf DSC Testosterone.pdf 08/20/2014
DSC Sodium Phosphate pdf DSC Sodium Phosphate.pdf 08/20/2014
DSC Fentanyl DSC Fentanyl.pdf 08/20/2014
OMB Memo/Abbreviated supporting statement OMB_generic_FG_clearance2_0910-0677.doc 08/26/2014
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.